Comparative study of different methodologies to detect the JAK2 V617F mutation in chronic BCR-ABL1 negative myeloproliferative neoplasms
Open Access
- 14 December 2015
- journal article
- Published by Elsevier BV in Practical Laboratory Medicine
- Vol. 4, 30-37
- https://doi.org/10.1016/j.plabm.2015.12.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The JAK2 exon 12 mutations: A comprehensive reviewAmerican Journal of Hematology, 2011
- Detection of the JAK2 V617F missense mutation by high resolution melting analysis and its validationClinica Chimica Acta; International Journal of Clinical Chemistry, 2009
- High Resolution Melting Analysis for JAK2 Exon 14 and Exon 12 Mutations: A Diagnostic Tool for Myeloproliferative NeoplasmsThe Journal of Molecular Diagnostics, 2009
- A Simple, Rapid, and Sensitive Method for the Detection of theJAK2V617F MutationAmerican Journal of Clinical Pathology, 2007
- The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia veraBlood, 2006
- Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation AnalysisThe Journal of Molecular Diagnostics, 2006
- Diagnostic Assays for the JAK2 V617F Mutation in Chronic Myeloproliferative DisordersAmerican Journal of Clinical Pathology, 2006
- Is the DNA Sequence the Gold Standard in Genetic Testing? Quality of Molecular Genetic Tests AssessedClinical Chemistry, 2006
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005